Adaptive clinical trial designs for phase I cancer studies (Q2452091)

From MaRDI portal
scientific article
Language Label Description Also known as
English
Adaptive clinical trial designs for phase I cancer studies
scientific article

    Statements

    Adaptive clinical trial designs for phase I cancer studies (English)
    0 references
    0 references
    0 references
    0 references
    30 May 2014
    0 references
    Bayesian designs
    0 references
    ``best intention'' designs
    0 references
    continual reassessment method
    0 references
    dose finding studies
    0 references
    estimation efficiency
    0 references
    ethics
    0 references
    maximum tolerated dose
    0 references
    oncology trial designs
    0 references
    optimal designs
    0 references
    phase I
    0 references
    stochastic approximation
    0 references
    toxicity
    0 references
    up-and-down designs
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references